Y. Miura

Streptococcus pyogenes TrxSR Two-Component System Regulates Biofilm Production in Acidic Environments

I. Tatsuno, M. Isaka, T. Hasegawa, 2021, Infection and immunity.

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.

M. Isaka, N. Goto, T. Taniguchi, 2000, Vaccine.

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.

M. Isaka, N. Goto, T. Taniguchi, 1998, Vaccine.

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.

M. Isaka, T. Taniguchi, Y. Yasuda, 1998, Vaccine.

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid.

M. Isaka, N. Goto, T. Taniguchi, 1999, Vaccine.